These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 27591241

  • 21. Intent to treat analysis of in vitro fertilization and preimplantation genetic screening versus expectant management in patients with recurrent pregnancy loss.
    Murugappan G, Shahine LK, Perfetto CO, Hickok LR, Lathi RB.
    Hum Reprod; 2016 Aug; 31(8):1668-74. PubMed ID: 27278003
    [Abstract] [Full Text] [Related]

  • 22. Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss.
    Mumford SL, Silver RM, Sjaarda LA, Wactawski-Wende J, Townsend JM, Lynch AM, Galai N, Lesher LL, Faraggi D, Perkins NJ, Schliep KC, Zarek SM, Schisterman EF.
    Hum Reprod; 2016 Mar; 31(3):657-65. PubMed ID: 26759138
    [Abstract] [Full Text] [Related]

  • 23. Pregnancy loss managed by cervical dilatation and curettage increases the risk of spontaneous preterm birth.
    McCarthy FP, Khashan AS, North RA, Rahma MB, Walker JJ, Baker PN, Dekker G, Poston L, McCowan LM, O'Donoghue K, Kenny LC, SCOPE Consortium.
    Hum Reprod; 2013 Dec; 28(12):3197-206. PubMed ID: 24052504
    [Abstract] [Full Text] [Related]

  • 24. Anti-Müllerian hormone and live birth in unexplained recurrent pregnancy loss.
    Bliddal S, Feldt-Rasmussen U, Forman JL, Hilsted LM, Larsen EC, Christiansen OB, Nielsen CH, Kolte AM, Nielsen HS.
    Reprod Biomed Online; 2023 Jun; 46(6):995-1003. PubMed ID: 37055255
    [Abstract] [Full Text] [Related]

  • 25. Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry.
    Grandone E, Tiscia GL, Mastroianno M, Larciprete G, Kovac M, Tamborini Permunian E, Lojacono A, Barcellona D, Bitsadze V, Khizroeva J, Makatsarya A, Cacciola R, Martinelli I, Bucherini E, De Stefano V, Lodigiani C, Colaizzo D, De Laurenzo A, Piazza G, Margaglione M.
    Hum Reprod; 2021 Jul 19; 36(8):2083-2090. PubMed ID: 34195794
    [Abstract] [Full Text] [Related]

  • 26. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial.
    Yamada H, Deguchi M, Saito S, Takeshita T, Mitsui M, Saito T, Nagamatsu T, Takakuwa K, Nakatsuka M, Yoneda S, Egashira K, Tachibana M, Matsubara K, Honda R, Fukui A, Tanaka K, Sengoku K, Endo T, Yata H.
    EClinicalMedicine; 2022 Aug 19; 50():101527. PubMed ID: 35795714
    [Abstract] [Full Text] [Related]

  • 27. Recurrent pregnancy loss: couples' perspectives on their need for treatment, support and follow up.
    Koert E, Malling GMH, Sylvest R, Krog MC, Kolte AM, Schmidt L, Nielsen HS.
    Hum Reprod; 2019 Feb 01; 34(2):291-296. PubMed ID: 30561641
    [Abstract] [Full Text] [Related]

  • 28. A proposed prognostic prediction tool for a live birth among women with recurrent pregnancy loss.
    Bashiri A, Giliutin M, Ziedenberg H, Plakht Y, Baumfeld Y.
    J Matern Fetal Neonatal Med; 2022 Oct 01; 35(19):3736-3742. PubMed ID: 33135531
    [Abstract] [Full Text] [Related]

  • 29. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme.
    Schleussner E, Kamin G, Seliger G, Rogenhofer N, Ebner S, Toth B, Schenk M, Henes M, Bohlmann MK, Fischer T, Brosteanu O, Bauersachs R, Petroff D, ETHIG II group.
    Ann Intern Med; 2015 May 05; 162(9):601-9. PubMed ID: 25938990
    [Abstract] [Full Text] [Related]

  • 30. Plasma level of mannose-binding lectin is associated with the risk of recurrent pregnancy loss but not pregnancy outcome after the diagnosis.
    Nørgaard-Pedersen C, Rom LH, Steffensen R, Kesmodel US, Christiansen OB.
    Hum Reprod Open; 2022 May 05; 2022(3):hoac024. PubMed ID: 35747402
    [Abstract] [Full Text] [Related]

  • 31. IL-10 gene promoter and intron polymorphisms and changes in IL-10 secretion in women with idiopathic recurrent miscarriage.
    Qaddourah RH, Magdoud K, Saldanha FL, Mahmood N, Mustafa FE, Mahjoub T, Almawi WY.
    Hum Reprod; 2014 May 05; 29(5):1025-34. PubMed ID: 24626804
    [Abstract] [Full Text] [Related]

  • 32. No evidence for mutations in NLRP7, NLRP2 or KHDC3L in women with unexplained recurrent pregnancy loss or infertility.
    Aghajanova L, Mahadevan S, Altmäe S, Stavreus-Evers A, Regan L, Sebire N, Dixon P, Fisher RA, Van den Veyver IB.
    Hum Reprod; 2015 Jan 05; 30(1):232-8. PubMed ID: 25376457
    [Abstract] [Full Text] [Related]

  • 33. Higher levels of procoagulant microparticles in women with recurrent miscarriage are not associated with antiphospholipid antibodies.
    Martínez-Zamora MA, Tàssies D, Creus M, Reverter JC, Puerto B, Monteagudo J, Carmona F, Balasch J.
    Hum Reprod; 2016 Jan 05; 31(1):46-52. PubMed ID: 26534898
    [Abstract] [Full Text] [Related]

  • 34. Chance of live birth: a nationwide, registry-based cohort study.
    Kolte AM, Westergaard D, Lidegaard Ø, Brunak S, Nielsen HS.
    Hum Reprod; 2021 Mar 18; 36(4):1065-1073. PubMed ID: 33394013
    [Abstract] [Full Text] [Related]

  • 35. Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride.
    Andersson IM, Benson L, Christensson K, Gemzell-Danielsson K.
    Hum Reprod; 2016 Jan 18; 31(1):67-74. PubMed ID: 26573530
    [Abstract] [Full Text] [Related]

  • 36. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
    Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S.
    Hum Reprod; 2013 Jul 18; 28(7):1743-52. PubMed ID: 23585559
    [Abstract] [Full Text] [Related]

  • 37. Signs and symptoms associated with early pregnancy loss: findings from a population-based preconception cohort.
    Sapra KJ, Buck Louis GM, Sundaram R, Joseph KS, Bates LM, Galea S, Ananth CV.
    Hum Reprod; 2016 Apr 18; 31(4):887-96. PubMed ID: 26936888
    [Abstract] [Full Text] [Related]

  • 38. A review of reproductive outcomes of women with two consecutive miscarriages and no living child.
    Green DM, O'Donoghue K.
    J Obstet Gynaecol; 2019 Aug 18; 39(6):816-821. PubMed ID: 31006300
    [Abstract] [Full Text] [Related]

  • 39. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T, Carp H, Shoenfeld Y.
    Harefuah; 2005 Jun 18; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [Abstract] [Full Text] [Related]

  • 40. Reproductive outcomes following recurrent first-trimester miscarriage: a retrospective cohort study.
    Linehan LA, San Lazaro Campillo I, Hennessy M, Flannery C, O'Donoghue K.
    Hum Reprod Open; 2022 Jun 18; 2022(4):hoac045. PubMed ID: 36339248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.